CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients

The Cannigma

MAY 19, 2021

While many countries around the world have legalized or decriminalized cannabis or have eased up on enforcement in recent years, in Japan in 2018 there was a sharp increase in cannabis-related arrests — and 80% of them were possession charges. of Japanese have reported consuming cannabis, as opposed to more than 40% in the US and Canada.

Law

FloridaMarijuana.net

AUGUST 15, 2018

Living with PTSD, no matter the underlying cause of the trauma, can be extremely difficult for patients and their loved ones. Medical marijuana and cannabinoids can be used to treat a patient’s physical and psychological health, alleviating the symptoms of PTSD.

Treatment

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development

MedicalJane

OCTOBER 3, 2019

The United States Department of Defense and GW Pharmaceuticals are collaborating on a new clinical trial at the Montefiore Medical Center in New York. Dr. Eric Hollander, the Director of the Autism and Obsessive Compulsive Spectrum Program and Anxiety and Depression Program at Montefiore Hospital, is leading the clinical trial.

Clinical Trials

The Cannigma

MARCH 7, 2022

What can the current clinical trials tell us? A common theme with cannabis is that more research is needed, so thankfully there are clinical trials in the works looking at the therapeutic utility of CBN. Where can I buy CBN? Is it even legal? As long as the product contains <0.3%

THC

The Cannigma

AUGUST 31, 2021

A 2018 research paper in the International Journal of Drug Policy analyzed in-depth interviews carried out with 24 Israeli physicians working in pain medicine, oncology, and family medicine, and found that “physicians discussed contrasting narratives of cananbi, presenting it as both a medicine and non-medicine.”

Education

Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. Of 272 combined patients, 86% experienced some clinical benefit, and 10% experienced a complete clinical response. improvement in good sleep.

Conditions

Cannabis Law Report

DECEMBER 14, 2019

million in the Melbourne cannabis firm in 2018. The uptick has been represented in the patient count, as well. Although we note the early stage of the sector in Australia and the associated volatility of a nascent industry, over the same period patient numbers domestically have continued to soar,” Bell and Smith wrote in their note.

Pharmaceutical

SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. However, with the database not yet available to the nation’s private clinics there are concerns over the quality and volume of data it will garner.

Data

Canna Law Blog

MARCH 4, 2020

In recent years, the United States has seen a proliferation of ketamine clinics. From 2015 to 2018, the number of clinics increased from 60 to 300; that number is undoubtedly higher today. People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs.

Therapy

Cannabis Law Report

JULY 6, 2021

David Bradley, Chief Executive of South London and Maudsley NHS Foundation Trust, said, “We believe this collaboration could accelerate much-needed research that will translate into evidence-based and direct patient care for people who use our services. London, UK – 5 July 2021.

Research and Development

Puff Puff Post

OCTOBER 3, 2019

The possibility of treating the symptoms associated with autism originated when the FDA approved Epidoliolex in 2018. Epidiolex is a CBD-infused oral-based medication designed to help patients as young as two-years-old treat epilepsy disorders. Epidiolex proved tremendously successful in treating epilepsy patients.

Research and Development

The Cannigma

JUNE 23, 2022

The study also found that CBGA interacts with numerous other important receptors in the body like GPR55, TRPV1 channels, as well as GABA receptors, supporting further consideration and research for use in epileptic patients. He noted, “The data in the study isn’t really ready for translation to the clinic.” Pain and inflammation.

Cannabinoids

The Joint Blog

AUGUST 27, 2020

The study found that medical cannabis use is associated with less frequent hospitalizations among patients living with sickle cell disease (SCD). It’s titled Medical marijuana certification for patients with sickle cell disease: A report of a single center experience. The study was published in the journal Blood Advances.

Patients

MedicalJane

MAY 21, 2020

A chronic neuropathic pain model was used that exposed mice to post-operative neuropathic pain equivalent to several years of chronic pain in human patients. The Hemp Farming Act of 2018. For several hours after the mice consumed the hemp oil, they demonstrated effective pain relief.

Oil

Cannabis Law Report

NOVEMBER 20, 2019

Since a new law took effect a year ago, England’s National Health Service (NHS) has reimbursed patients on only 18 occasions for “unlicensed” cannabis-based products that have not undergone clinical trials, according to government data. All other cannabis-based medicines are unlicensed.

Clinical Trials

Cannabis Law Report

JULY 9, 2021

Patients would participate in therapy sessions to prepare for the use of psychedelics, after which the substances would be administered under the guidance and supervision of trained medical professionals. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , Clinical Trial ID NCT03866174, available at [link].

Law

Cannabis Law Report

AUGUST 19, 2021

. – ‘No definitive evidence’ – British charity Versus Arthritis recommends patients contemplating CBD should consult their doctor beforehand, and also wants more work done to understand its impact. LDN CBD launched in 2018 to tap into the new market, and is seeking a new round of financing to fund expansion.

Cannabinoids

Cannabis Law Report

AUGUST 21, 2019

In November 2018, the legal status of cannabis was changed to allow specialist clinicians to legally prescribe cannabis-derived medicinal products to patients with an exceptional clinical need, following a high-profile media campaign. This would answer questions about safety and efficacy, they said.

Clinical Trials

Cannabis Law Report

SEPTEMBER 1, 2021

The company recently became the industry’s first firm to list on the NYSE American exchange and their psilocybin clinical trial for depression is making excellent progress. His background is a mix of cognitive psychology, clinical psychology and computer science. After Approval, It’s Off to Treatment Clinics.

Research and Development

Cannabis Law Report

AUGUST 19, 2019

There have been more than 7,500 approvals for medicinal cannabis in Australia since legalisation in 2016 – so why don’t we know if it is helping patients? Access to medicinal cannabis for patients was legalised in Australia in 2016, allowing doctors to request permission to prescribe from the Australian government.

Medicine

MMJ Recs

NOVEMBER 20, 2023

These compounds may help reduce symptoms and improve the quality of life for patients. Cannabis Research and Patient Outcomes The scientific exploration of cannabinoids and their therapeutic effects has opened the door to numerous research initiatives. The outcomes of these studies have had a profound impact on patient care.

Cannabinoids

The Cannigma

MAY 9, 2023

However, in 2019, the Jordanian government announced its plans to conduct clinical trials on the use of cannabis for medical purposes. 1 Hemp in Jordan In 2018, the Jordanian government legalized the cultivation of industrial hemp for certain purposes, such as the production of textiles and building materials.

Law

Cannabis Law Report

NOVEMBER 13, 2019

Denmark is already leading the way by launching a Big Pharma modelled 4-year medical marijuana trial in early 2018, following a unanimous vote in Parliament. Coupled with transit time and testing in the EU, delays could impact the shelf-life of product patients will receive,” he said. Arundati Dandapani. Founder and CEO, .

Clinical Trials

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

After securing FDA approval in June of 2018, Epidiolex’s manufacturer GW Pharma announced the drug should enter the consumer market by the end of 2018. The only side effects reported from Epidiolex clinical trials were sleepiness, sedation, insomnia, fatigue, diarrhea, rash, and some infections.

Research and Development

Canna Care Docs

DECEMBER 11, 2018

A study published in the journal, Chemistry & Biodiversity , noted “marked improvement” in the quality of sleep in patients with chronic pain problems. [5] “Americans Who Smoke Marijuana By Age Group 2017 | Statistic” 2018. Accessed December 5 2018. Accessed December 5 2018. References. Hill, Kevin P.,

Chronic Pain

Cannabis Law Report

JANUARY 14, 2022

Right-to-try aims to allow patients who have been diagnosed with life-threatening diseases or conditions who have tried all approved treatment options and who are unable to participate in a clinical trial to access certain unapproved treatments. Right-to-try permits those patients to have access to investigational drugs.

Treatment

MedicalJane

JUNE 29, 2018

On June 26, 2018, the FDA granted approval of Epidiolex, a cannabidiol (CBD) oral solution, to GW Research Ltd (GW). The new drug is indicated for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. branch of Aphria, Inc.,

Clinical Trials

Cannabis Law Report

MAY 31, 2022

The first path, that of traditional medicine, currently offers patients limited options. The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. 2022 Active FDA Clinical Trials and State-Regulated Systems.

Clinical Trials

The Cannigma

MAY 6, 2021

The popularity of hemp can be traced back to the 2018 Farm Bill, a piece of legislation that effectively legalized hemp, which is defined as cannabis containing less than 0.3% The only clinical trial on delta-8-THC involving humans was done on children in Israel in 1995. Is Delta 8 THC legal? grandbrothers/123rf). delta-9-THC.

THC

CannaMD

NOVEMBER 8, 2019

Medical Marijuana Patients Still Receive VA Benefits. While VA doctors can’t prescribe or recommend medical marijuana ( that’s what we do ), they also can’t withhold benefits because you’re a medical cannabis patient. VA clinicians may not recommend medical marijuana. PTSD Studies Support Cannabis.

Marijuana

CannaMD

NOVEMBER 15, 2020

His findings are sure to alarm medical cannabis professionals and patients alike. In Canada, recreational marijuana use was legalized in October 2018. While the government may be behind, CannaMD physicians are leading the charge – collaborating on multiple university research studies and educating patients at every opportunity.

DEA

CannaMD

AUGUST 8, 2020

More recently, the 2018 Farm Bill expanded hemp legislation. 27, 2018, the DEA announced a rule change that placed “FDA-approved drugs that contain CBD derived from cannabis and no more than 0.1 On June 25, 2018, Epidiolex became the first FDA approved cannabis-derived medication to hit U.S. In 1970, the U.S.

CBD

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Patients using warfarin need to have their blood INR level tested after adding THC-containing cannabis to their regimen. topiramate. rufinamide. zonisamide. eslicarbazepine.

CBD

SpeedWeed

DECEMBER 28, 2018

In my defense, 2018 has been a wild ride in the world of weed, a 12-month timespan which truly could be called “the best of times and the worst of times,” or perhaps just the highest and lowest of times. The Top 10 Cannabis Stories of 2018. But until then, here are the buzzes and bummers 2018 had to offer.

Pharmaceutical

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Silver Spring, MD: US Food and Drug Administration; June 25, 2018.

CBD